3rd National Scientific Conference on Thalassemia

On Apr 24-25, 2019, the Vietnam Thalassemia Association, in collaboration with the National Institute of Hematology and Blood Transfusion and related organizations, held the 3rd Scientific Conference on Thalassemia in Hanoi, in response to World Thalassemia Day on May 8, with the message:

"Joining hands to push back thalassemia for the health of the Vietnamese bloodline."

Leading international scientists on Thalassemia from the Asian region at the 3rd Thalassemia Conference (source: National Institute of Hematology and Blood Transfusion)

The conference set out objectives for surveying Thalassemia disease genes by population group, geographic region, and ethnicity. Through this, epidemiological information on Thalassemia will provide an overall picture for timely prevention, detection, and treatment.

Dr. Nguyen Thi Thu Ha, Director of the Thalassemia Center, National Institute of Hematology and Blood Transfusion, presenting at the Conference

Dr. Nguyen Thi Thu Ha, Director of the Thalassemia Center, National Institute of Hematology and Blood Transfusion, presenting conclusions from the Thalassemia survey of 38 ethnic groups

According to 2017 statistics, more than 12 million people in Vietnam currently carry a Thalassemia gene. This is a problem for society as a whole, seriously affecting the quality of the population. Prevention is the most effective control measure, together with the involvement of ministries, departments, authorities at all levels, and society as a whole to help control the disease, curb the spread of disease genes, reduce the number of children born with the disease, improve patients' quality of life, and raise the quality of Vietnam's population.

Dr. Duong Quoc Chinh, Head of the Department of Genetics and Molecular Biology, National Institute of Hematology and Blood Transfusion, presenting on testing methods. Among them, new Thalassemia variants were detected by next-generation sequencing (NGS)

In-depth presentations by specialist physicians and PhD scientists showed that new mutation types of thalassemia have been discovered in Vietnam that had never been published before, as well as types that are rare among Vietnamese people. Screening results from molecular testing methods using next-generation sequencing (NGS) technology have helped to better control epidemiological information on Thalassemia and to use appropriate molecular testing tools in the prevention and control of the disease.

Prof. Suthat Fucharoen, Mahidol University and Institute of Molecular Biosciences, sharing achievements in Thalassemia testing and diagnosis.

Prof. Suthat Fucharoen, Mahidol University and Institute of Molecular Biosciences - happily sharing about connecting with international hematology journals through highly meaningful Thalassemia publications based on new molecular testing methods.

VIET HUY Technological Scientific Equipment Co., Ltd is also one of the organizations that always seeks to work alongside physicians and laboratory departments to support them and provide comprehensive testing solutions for Thalassemia prevention, including diagnosis of disease types and premarital genetic counseling, toward a brighter future for thalassemia care in Vietnam.

Thalassemia testing method based on next-generation sequencing (NGS) technology. The method enables comprehensive diagnosis of both Alpha and Beta thalassemia.

Dr. Phan Thi Thuy Hoa at the Viet Huy booth displaying hematology, cancer, and Thalassemia - NGS testing products

The VIET HUY Technological Scientific Equipment Co., Ltd booth

Thalassemia awareness materials at the 3rd Thalassemia Conference

Awareness materials on thalassemia testing and prevention at the conference

References: National Institute of Hematology and Blood Transfusion,

Nhan Dan Television